Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxytocin-based Pharmacotherapy for Autism Spectrum Disorders: Investigating the Neural and Behavioral Effects of a Promising Intervention Approach

NCT02940574 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT02940574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02940574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxytocin-based Pharmacotherapy for Autism Spectrum Disorders: Investigating the Neural and Behavioral Effects of a Promising Intervention Approach
Lead sponsor
KU Leuven
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2015
Completion date
December 31, 2019
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders